RAPT Therapeutics, Inc.
RAPT
$0.906
-$0.0151-1.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -188.89% | 33.37% | 9.36% | 1.15% | 1.58% |
| Total Depreciation and Amortization | -3.37% | -2.62% | -2.87% | -2.79% | -0.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.02% | -11.95% | 4.42% | 31.93% | 13.17% |
| Change in Net Operating Assets | 1,027.80% | 32.13% | -220.68% | -89.49% | -117.03% |
| Cash from Operations | 40.77% | 37.41% | -3.95% | 2.41% | -26.82% |
| Capital Expenditure | 94.12% | -1,800.00% | 100.95% | -56.72% | -1.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.56% | -3.90% | 20.14% | -22.77% | -19.79% |
| Cash from Investing | -104.57% | -4.00% | 20.94% | -23.02% | -19.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -92.24% | 1,872.93% | 332.08% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -92.24% | 1,872.93% | 332.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 15,918.83% | 109.99% | -281.30% | 67.54% | -267.64% |